EAT is up +49.38%% since April’24 pick View All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ATRX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for Adhera Therapeutics, Inc.
(Updated on Jun 26, 2024)

Hold candidate since Jun 20, 2024 PDF

No changes to the price of Adhera Therapeutics, Inc. stock on the last trading day (Wednesday, 26th Jun 2024). During the last trading day the stock fluctuated 0% from a day low at $0.0011 to a day high of $0.0011. The price has been going up and down for this period, and there has been a -73.81% loss for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ATRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 17, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Adhera Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0011 and $0.0040. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Adhera Therapeutics, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Adhera Therapeutics, Inc. is oversold on RSI14 (6). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: $0.0010 (-6.88%) (This stock has low daily movements and this gives low risk. Low RSI14 is 6 which reduces the risk some. There is a buy signal from a pivot bottom found 27 days ago.)

Trading Expectations (ATRX) For The Upcoming Trading Day Of Thursday 27th

For the upcoming trading day on Thursday, 27th we expect Adhera Therapeutics, Inc. to open at $0.0011, and during the day (based on 14 day Average True Range), to move between $0.0007 and $0.0015, which gives a possible trading interval of +/-$0.0004 (+/-34.74%) up or down from last closing price. If Adhera Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 69.47% move between the lowest and the highest trading price during the day.

Is Adhera Therapeutics, Inc. stock A Buy?

Adhera Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Adhera Therapeutics, Inc. of Thursday, June 27, 2024

Fair opening price June 27, 2024 Current price
$0.0011 ( 0%) $0.0011

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ATRX

Fibonacci Support & Resistance Levels

Level Price
R3 0.0011 -
R2 0.0011 -
R1 0.0011 -
Price 0.0011
S1 0.0011 -
S2 0.0011 -
S3 0.0011 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 0.0011
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Adhera Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Adhera Therapeutics, Inc. is ATRX and it is traded on the PINK (Pink Sheets).

Should I buy or sell Adhera Therapeutics, Inc. Stock?
Adhera Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Adhera Therapeutics, Inc. Stock?
Adhera Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Adhera Therapeutics, Inc. Stock.

What's the current price of Adhera Therapeutics, Inc. Stock?
As of the end of day on the Jun 26, 2024, the price of an Adhera Therapeutics, Inc. (ATRX) share was $0.0011.

What is the 52-week high and low for Adhera Therapeutics, Inc. Stock?
The 52-week high for Adhera Therapeutics, Inc. Stock is $0.0800 and the 52-week low is $0.0011.

What is the market capitalization of Adhera Therapeutics, Inc. Stock?
As of the Jun 26, 2024, the market capitalization of Adhera Therapeutics, Inc. is 15.501K.
Click to get the best stock tips daily for free!

About Adhera Therapeutics, Inc.

Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.... ATRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT